Form D · Private Equity Fund
OrbiMed Asia Partners IV, L.P.
New York, NY · CIK 0001796011
Offering snapshot reported Sep 2, 2020 · SEC filing
- Reported sold
- $487M Offering amount: $750M
- Investors reported
- 86 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 86
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2020 | Amendment | $486,882,011 | No comparison | 86 | SEC filing |
| Mar 5, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-362067
Paid based on percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| J.P. Morgan Securities LLC | 79 |
Source: Form D, filed Sep 2, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sven H. Borho | Director |
| Carl L. Gordon | Director |
| W. Carter Neild | Director |
| N/A Orbi Med Advisors Iv Limited | Executive, Promoter |
| N/A Orbi Med Asia Gp Iv, L.P. | Executive, Promoter |
| Sunny Sharma | Director |
| Jonathan T. Silverstein | Director |
| David G. Wang | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
601 Lexington Avenue, 54 Th Floor
New York, NY, 10022
New York, NY, 10022